Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2

Summary

Early identification and treatment of this inflammatory cascade using existing therapeutic strategies with proven safety profiles could change the course and prognosis of COVID-19 infection, reducing mortality rates. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death

Timeline

Start

2023-02-28

Primary completion

2023-11-01

Completion

2023-12-01

Drugs

Indications